“『 YEOTOP3.COM 』 여탑애오개오피Ⅵ애오개건마✼애오개출장ⅱ애오개립카페☌애오개오피❊애오개키스방ぷ애오개스파”的搜索结果，显示 261-270 项，共有 11461 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   2. A second purpose of this study is to obtain blood and tissue samples from participants having or at risk for developing cancer of the liver or bile ducts or ...

2. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The aims of this study are to investigate the presence of tumor cells after filtration of autologous blood products by intraoperative cell saver, ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) ...

5. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

8. 肺科- 临床试验- 妙佑医疗国际

   The purpose of this study is to collect medical and personal histories, blood and/or tumor tissue samples from patients who are long-term survivors of lung ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to determine the safety and tolerability of and to define the maximum tolerated dose (MTD) and Recommended Phase 2 ...